Vicki L. Sato
Director, Bristol-Myers Squibb.
Companies
- Allogene Therapeutics, Inc.Board member Aug 3, 2021 to now1
- VIR BiotechnologyBoard member Oct 10, 2019 to now2
- Denali Therapeutics Inc.Board member Dec 7, 2017 to Jan 3, 20253
- Akouos, Inc.Board member Jun 25, 2020 to Dec 2, 20224
- Bristol-Myers SquibbBoard member Jul 20, 2006 to Feb 3, 20215
- BorgWarnerBoard member Feb 21, 2014 to May 1, 20206
- Syros Pharmaceuticals, Inc.Board member Jun 29, 2016 to Jun 12, 20197
- Revvity Inc.Board member Apr 29, 2004 to Feb 10, 20178
- Alnylam PharmaceuticalsBoard member Jun 5, 2007 to Jun 4, 20109
- INFINITY PHARMACEUTICALS, INC.Board member Sep 13, 2006 to May 23, 200810
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- VIR Biotechnology VIR1,078,391 shares11$11.0M at $10.23May 1, 2026
Revvity Inc. RVTY29,970 shares12$4.6M at $152.28Feb 9, 2017- Denali Therapeutics Inc. DNLI107,976 shares13$2.0M at $18.25Jan 2, 2025
- Allogene Therapeutics, Inc. ALLO162,575 shares14$208.4K at $1.28Jun 5, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- May 1, 2026Sold 22,000 shares at $10.05 of VIR Biotechnology11
- Apr 1, 2026Sold 22,000 shares at $9.07 of VIR Biotechnology15
- Mar 2, 2026Sold 200 shares at $9.98 of VIR Biotechnology16
- Mar 2, 2026Sold 21,800 shares at $9.50 of VIR Biotechnology16
- Feb 24, 2026Sold 200 shares at $10.26 of VIR Biotechnology17
- Feb 24, 2026Sold 42,177 shares at $9.75 of VIR Biotechnology17
- Feb 24, 2026Exercised options 42,377 shares at $1.49 of VIR Biotechnology17
- Feb 2, 2026Sold 22,000 shares at $7.71 of VIR Biotechnology18
- Jan 2, 2026Sold 22,000 shares at $5.93 of VIR Biotechnology19
- Dec 1, 2025Sold 22,000 shares at $6.00 of VIR Biotechnology20
- Nov 3, 2025Sold 22,000 shares at $5.64 of VIR Biotechnology21
- Oct 1, 2025Sold 22,000 shares at $5.84 of VIR Biotechnology22
- Sep 2, 2025Sold 22,000 shares at $4.99 of VIR Biotechnology23
- Aug 1, 2025Sold 22,000 shares at $4.99 of VIR Biotechnology24
- Jul 1, 2025Sold 22,000 shares at $5.10 of VIR Biotechnology25
- May 30, 2025Granted 8,000 shares of VIR Biotechnology26
- Jan 8, 2025Sold 10,960 shares at $12.52 of VIR Biotechnology27
- Jan 2, 2025Sold 3,080 shares at $20.91 of Denali Therapeutics Inc.13
- Nov 7, 2024Sold 1,020 shares at $30.00 of Denali Therapeutics Inc.28
- Nov 1, 2024Sold 3,080 shares at $27.07 of Denali Therapeutics Inc.29
- Sep 13, 2024Sold 1,020 shares at $30.00 of Denali Therapeutics Inc.30
- Sep 3, 2024Sold 100 shares at $25.37 of Denali Therapeutics Inc.31
- Sep 3, 2024Sold 2,980 shares at $24.99 of Denali Therapeutics Inc.31
- Jul 1, 2024Sold 100 shares at $22.86 of Denali Therapeutics Inc.32
- Jul 1, 2024Sold 2,980 shares at $22.12 of Denali Therapeutics Inc.32
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARVIR Biotechnology, Board member
- 3
- 4SEC EDGARAkouos, Inc., Board member
- 5SEC EDGARBristol-Myers Squibb, Board member
- 6SEC EDGARBorgWarner, Board member
- 7
- 8SEC EDGARRevvity Inc., Board member
- 9
- 10
- 11
- 12
- 13
- 14
- 15SEC EDGARForm 4 filed Apr 2, 2026
- 16SEC EDGARForm 4 filed Mar 3, 2026
- 17SEC EDGARForm 4 filed Feb 26, 2026
- 18SEC EDGARForm 4 filed Feb 3, 2026
- 19SEC EDGARForm 4 filed Jan 5, 2026
- 20SEC EDGARForm 4 filed Dec 2, 2025
- 21SEC EDGARForm 4 filed Nov 4, 2025
- 22SEC EDGARForm 4 filed Oct 2, 2025
- 23SEC EDGARForm 4 filed Sep 3, 2025
- 24SEC EDGARForm 4 filed Aug 4, 2025
- 25SEC EDGARForm 4 filed Jul 2, 2025
- 26SEC EDGARForm 4 filed Jun 2, 2025
- 27SEC EDGARForm 4 filed Jan 8, 2025
- 28SEC EDGARForm 4 filed Nov 12, 2024
- 29SEC EDGARForm 4 filed Nov 5, 2024
- 30SEC EDGARForm 4 filed Sep 16, 2024
- 31SEC EDGARForm 4 filed Sep 4, 2024
- 32SEC EDGARForm 4 filed Jul 3, 2024